Your browser doesn't support javascript.
loading
Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer.
Orouji, Elias; Raman, Ayush T; Singh, Anand K; Sorokin, Alexey; Arslan, Emre; Ghosh, Archit K; Schulz, Jonathan; Terranova, Christopher; Jiang, Shan; Tang, Ming; Maitituoheti, Mayinuer; Callahan, Scot C; Barrodia, Praveen; Tomczak, Katarzyna; Jiang, Yingda; Jiang, Zhiqin; Davis, Jennifer S; Ghosh, Sukhen; Lee, Hey Min; Reyes-Uribe, Laura; Chang, Kyle; Liu, Yusha; Chen, Huiqin; Azhdarinia, Ali; Morris, Jeffrey; Vilar, Eduardo; Carmon, Kendra S; Kopetz, Scott E; Rai, Kunal.
Afiliación
  • Orouji E; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Raman AT; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Singh AK; Broad Institute of MIT and Harvard, Cambridge, Massachussetts, USA.
  • Sorokin A; Graduate Program in Quantitative and Computational Biosciences, Baylor College of Medicine, Houston, Texas, USA.
  • Arslan E; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ghosh AK; Department of GI Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Schulz J; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Terranova C; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Jiang S; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Tang M; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Maitituoheti M; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Callahan SC; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Barrodia P; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Tomczak K; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Jiang Y; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Jiang Z; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Davis JS; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ghosh S; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Lee HM; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Reyes-Uribe L; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Chang K; Department of GI Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Liu Y; Department of GI Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Chen H; Center for Translational Cancer Research, University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Azhdarinia A; Department of GI Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Morris J; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Vilar E; Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Carmon KS; Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kopetz SE; University of Chicago Medical Center, Chicago, Illinois, USA.
  • Rai K; Department of GI Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Gut ; 71(5): 938-949, 2022 05.
Article en En | MEDLINE | ID: mdl-34059508
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cromatina / Neoplasias Colorrectales Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Gut Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cromatina / Neoplasias Colorrectales Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Gut Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido